Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

NCT06532565 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GS-2121
DRUG: Zimberelimab

Sponsor

Gilead Sciences